Jingda Biotechnology Overview
- Year Founded
-
2020
- Status
-
Private
- Latest Deal Type
-
Series A
- Investors
-
1
Jingda Biotechnology General Information
Description
Operator of a biopharmaceutical and biotechnology platform based in Shanghai, China. The company specailises in the development of gene and cell drugs, specifically NK and CAR-NK drugs.
Contact Information
Corporate Office
- Room C02, Block A, Phase 2
- Maple Grove International Center
- Shanghai
- China
Corporate Office
- Room C02, Block A, Phase 2
- Maple Grove International Center
- Shanghai
- China
Jingda Biotechnology Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 1. Early Stage VC (Series A) | 04-Mar-2025 | Completed | Generating Revenue |
Jingda Biotechnology Investors (1)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| DFJ Fund | Venture Capital | Minority |
Jingda Biotechnology FAQs
-
When was Jingda Biotechnology founded?
Jingda Biotechnology was founded in 2020.
-
Where is Jingda Biotechnology headquartered?
Jingda Biotechnology is headquartered in Shanghai, China.
-
What industry is Jingda Biotechnology in?
Jingda Biotechnology’s primary industry is Biotechnology.
-
Is Jingda Biotechnology a private or public company?
Jingda Biotechnology is a Private company.
-
What is Jingda Biotechnology’s current revenue?
The current revenue for Jingda Biotechnology is .
-
Who are Jingda Biotechnology’s investors?
DFJ Fund has invested in Jingda Biotechnology.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process